WallStSmart

Arthur J Gallagher & Co (AJG)vsEthos Technologies Inc. Class A Common Stock (LIFE)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Arthur J Gallagher & Co generates 2822% more annual revenue ($14.20B vs $485.82M). AJG leads profitability with a 11.4% profit margin vs -22.1%. AJG earns a higher WallStSmart Score of 72/100 (B).

AJG

Strong Buy

72

out of 100

Grade: B

Growth: 8.7Profit: 6.0Value: 5.7Quality: 5.5
Piotroski: 4/9Altman Z: 0.76

LIFE

Hold

45

out of 100

Grade: D

Growth: 10.0Profit: 2.0Value: 5.0Quality: 7.5
Piotroski: 5/9Altman Z: 1.29

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

AJG6 strengths · Avg: 8.8/10
Revenue GrowthGrowth
34.6%10/10

Revenue surging 34.6% year-over-year

Debt/EquityHealth
0.0510/10

Conservative balance sheet, low leverage

Market CapQuality
$52.87B9/10

Large-cap with strong market position

PEG RatioValuation
0.888/10

Growing faster than its price suggests

Price/BookValuation
2.2x8/10

Reasonable price relative to book value

Operating MarginProfitability
28.4%8/10

Strong operational efficiency at 28.4%

LIFE4 strengths · Avg: 9.5/10
Revenue GrowthGrowth
103.5%10/10

Revenue surging 103.5% year-over-year

EPS GrowthGrowth
161.6%10/10

Earnings expanding 161.6% YoY

Debt/EquityHealth
0.0510/10

Conservative balance sheet, low leverage

Price/BookValuation
1.8x8/10

Reasonable price relative to book value

Areas to Watch

AJG3 concerns · Avg: 3.0/10
P/E RatioValuation
33.3x4/10

Premium valuation, high expectations priced in

Return on EquityProfitability
6.8%3/10

ROE of 6.8% — below average capital efficiency

Altman Z-ScoreHealth
0.762/10

Distress zone — elevated risk

LIFE4 concerns · Avg: 2.0/10
Market CapQuality
$1.60B3/10

Smaller company, higher risk/reward

Return on EquityProfitability
-24.4%2/10

ROE of -24.4% — below average capital efficiency

Altman Z-ScoreHealth
1.292/10

Distress zone — elevated risk

Profit MarginProfitability
-22.1%1/10

Currently unprofitable

Comparative Analysis Report

WallStSmart Research

Bull Case : AJG

The strongest argument for AJG centers on Revenue Growth, Debt/Equity, Market Cap. Revenue growth of 34.6% demonstrates continued momentum. PEG of 0.88 suggests the stock is reasonably priced for its growth.

Bull Case : LIFE

The strongest argument for LIFE centers on Revenue Growth, EPS Growth, Debt/Equity. Revenue growth of 103.5% demonstrates continued momentum.

Bear Case : AJG

The primary concerns for AJG are P/E Ratio, Return on Equity, Altman Z-Score.

Bear Case : LIFE

The primary concerns for LIFE are Market Cap, Return on Equity, Altman Z-Score.

Key Dynamics to Monitor

AJG profiles as a growth stock while LIFE is a hypergrowth play — different risk/reward profiles.

LIFE is growing revenue faster at 103.5% — sustainability is the question.

AJG generates stronger free cash flow (921M), providing more financial flexibility.

Monitor INSURANCE BROKERS industry trends, competitive dynamics, and regulatory changes.

Bottom Line

AJG scores higher overall (72/100 vs 45/100) and 34.6% revenue growth. Both earn "Strong Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Arthur J Gallagher & Co

FINANCIAL SERVICES · INSURANCE BROKERS · USA

Arthur J. Gallagher & Co. (AJG) is an American global insurance brokerage and risk management services firm headquartered in Rolling Meadows, Illinois.

Ethos Technologies Inc. Class A Common Stock

FINANCIAL SERVICES · INSURANCE BROKERS · USA

aTyr Pharma, Inc., a clinical-stage biotherapeutics company, is dedicated to the discovery and development of drugs based on new immune pathways in the United States. The company is headquartered in San Diego, California.

Want to dig deeper into these stocks?